Patients were on SGLT-2i for an average of approximately 46 weeks at randomization
A closer look at the study Researchers reviewed the medical records of more than two million Veterans using GLP-1 therapies for type 2 diabetes, comparing outcomes across 175 areas of health from the heart and kidneys to the brain and immune system
Identification and characterization of a novel type of membrane-associated prostaglandin E synthase
Full-dose GLP-1 therapy focuses on treating obesity and metabolic disease
At Phoenix NP, we prescribe only brand-name Wegovy, Zepbound, and Foundayo sourced directly from the manufacturers (NovoCare and Lilly Direct)
Lifestyle Still Matters Medications are support tools, not replacements for movement, nutrition, and sleep hygiene